Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bailing capsule for stable COPD with frequent exacerbations (ChiCTR2400081575)
ChiCTR2400081575Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bailing jiaonang in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Number of AECOPD episodes and Main symptoms of COPD / TCM syndrome score (lung-kidney deficiency). Planned start Mar 2024; status: not yet recruiting.
02
Drugs
bailing jiaonang
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2400081575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081575.